Intimation of email sent to shareholders of the Company regarding TDS
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has declared an interim dividend of 100%, i.e., Rs. 1 per equity share (face value Rs. 1) for FY 2025-26, approved at the Board meeting held on July 31, 2025. The record date for eligibility is August 8, 2025, and the dividend will be paid within 30 days. The company has sent an email to shareholders explaining the applicable TDS rates — 10% for resident shareholders with valid PAN, 20% for those without PAN or with PAN not linked to Aadhaar, and higher rates for non-residents. Shareholders with total dividends up to Rs. 10,000 in the year, or those submitting valid Form 15G/15H, will face no TDS deduction.
A modest interim dividend of Rs. 1 per share. This is a routine TDS communication and does not change the company's fundamentals. Shareholders should ensure PAN-Aadhaar linkage and submit required documents by August 7, 2025, to avoid higher tax deduction.